These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 10803530

  • 21. [Comparison of blast cell sensitivity to low-intensity laser radiation and chemotherapeutic drugs].
    Karu TI, Riabykh TP, Sidorova TA, Dobrynin IaV.
    Dokl Akad Nauk; 1997 Mar; 353(1):114-7. PubMed ID: 9273047
    [No Abstract] [Full Text] [Related]

  • 22. [Cure of acute myeloblastic leukemia in a child with Down syndrome and tetralogy of Fallot].
    Balcar-Boroń A, Nowaczyk-Michalak A, Graduszewska-Czerebiej K.
    Wiad Lek; 1992 Mar; 45(5-6):220-3. PubMed ID: 1455866
    [No Abstract] [Full Text] [Related]

  • 23. Glutathione in childhood acute leukaemias.
    Kearns P, Pieters R, Rottier MM, Veerman AJ, Schmiegalow K, Pearson AD, Hall AG.
    Adv Exp Med Biol; 1999 Mar; 457():211-6. PubMed ID: 10500796
    [Abstract] [Full Text] [Related]

  • 24. Differential in vitro cytotoxicity does not explain increased host toxicities from chemotherapy in Down syndrome acute lymphoblastic leukemia.
    Valle M, Plon SE, Rabin KR.
    Leuk Res; 2009 Feb; 33(2):336-9. PubMed ID: 18718659
    [Abstract] [Full Text] [Related]

  • 25. Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
    Simon JH, Tebbi CK, Freeman AI, Brecher ML, Green DM, Sandberg AA.
    Cancer; 1987 Nov 15; 60(10):2515-20. PubMed ID: 2959356
    [Abstract] [Full Text] [Related]

  • 26. Etoposide pharmacokinetics in children treated for acute myeloid leukemia.
    Palle J, Frost BM, Gustafsson G, Hellebostad M, Kanerva J, Liliemark E, Schmiegelow K, Lönnerholm G, Nordic Society of Paediatric Haematology and Oncology.
    Anticancer Drugs; 2006 Oct 15; 17(9):1087-94. PubMed ID: 17001183
    [Abstract] [Full Text] [Related]

  • 27. Acute leukemias in children with Down syndrome.
    Zwaan CM, Reinhardt D, Hitzler J, Vyas P.
    Hematol Oncol Clin North Am; 2010 Feb 15; 24(1):19-34. PubMed ID: 20113894
    [Abstract] [Full Text] [Related]

  • 28. Continuous and high-dose cytarabine combined chemotherapy in children with down syndrome and acute myeloid leukemia: Report from the Japanese children's cancer and leukemia study group (JCCLSG) AML 9805 down study.
    Taga T, Shimomura Y, Horikoshi Y, Ogawa A, Itoh M, Okada M, Ueyama J, Higa T, Watanabe A, Kanegane H, Iwai A, Saiwakawa Y, Kogawa K, Yamanaka J, Tsurusawa M.
    Pediatr Blood Cancer; 2011 Jul 15; 57(1):36-40. PubMed ID: 21557456
    [Abstract] [Full Text] [Related]

  • 29. Neuropsychological late effects of treatment for acute leukemia in children with Down syndrome.
    Roncadin C, Hitzler J, Downie A, Montour-Proulx I, Alyman C, Cairney E, Spiegler BJ.
    Pediatr Blood Cancer; 2015 May 15; 62(5):854-8. PubMed ID: 25545182
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Down's syndrome with acute myeloid leukemia.
    Singh VP, Sundar S, Kumar K, Shukla J, Dube B.
    J Assoc Physicians India; 1994 Aug 15; 42(8):621. PubMed ID: 7868556
    [No Abstract] [Full Text] [Related]

  • 33. Ex vivo drug resistance profile in childhood acute myelogenous leukemia: no drug is more effective in comparison to acute lymphoblastic leukemia.
    Styczynski J, Wysocki M, Debski R, Juraszewska E, Malinowska I, Stanczak E, Ploszynska A, Stefaniak J, Mazur B, Szczepanski T.
    Leuk Lymphoma; 2002 Sep 15; 43(9):1843-8. PubMed ID: 12685842
    [Abstract] [Full Text] [Related]

  • 34. Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule.
    Damon LE, Johnston LJ, Ries CA, Rugo HS, Case D, Ault K, Linker CA.
    Cancer Chemother Pharmacol; 2004 Jun 15; 53(6):468-74. PubMed ID: 15138711
    [Abstract] [Full Text] [Related]

  • 35. Differential antileukemic activity of prednisolone and dexamethasone in freshly isolated leukemic cells.
    Mihál V, Hajdúch M, Nosková V, Feketová G, Jess K, Gojová L, Kaspárek I, Starý J, Blazek B, Pospísilová D, Novák Z.
    Adv Exp Med Biol; 1999 Jun 15; 457():461-71. PubMed ID: 10500823
    [Abstract] [Full Text] [Related]

  • 36. Improved outcome of acute myeloid leukaemia in Down's syndrome.
    Craze JL, Harrison G, Wheatley K, Hann IM, Chessells JM.
    Arch Dis Child; 1999 Jul 15; 81(1):32-7. PubMed ID: 10373130
    [Abstract] [Full Text] [Related]

  • 37. The management of neoplastic disorders of haematopoiesis in children with Down's syndrome.
    Lange B.
    Br J Haematol; 2000 Sep 15; 110(3):512-24. PubMed ID: 10997960
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Down syndrome and acute myeloid leukemia. Lessons learned from experience with high-dose Ara-C containing regimens.
    Ravindranath Y, Taub JW.
    Adv Exp Med Biol; 1999 Sep 15; 457():409-14. PubMed ID: 10500816
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.